Director Supply Chain
Vaxcyte
Director Supply Chain
Vaxcyte
Develops broad-spectrum vaccines for bacterial infections
We are seeking a highly skilled and experienced Director, Supply Chain, ERP Transformation, to join our dynamic team. As we transition from a clinical-stage organization to a fully integrated commercial biotech company, we are building the foundational capabilities essential to reliably deliver our first commercial vaccine to patients.
The Director, Supply Chain ERP Transformation role will play a pivotal leadership role in designing and implementing the end-to-end processes required to support this transformation. This is a business role and not a technology role. In this role, you will lead a team of process leaders in developing and executing Plan-to-Deliver capabilities—including planning, scheduling, production, quality release, and logistics—as well as overseeing the comprehensive Direct Procure-to-Pay process, including purchasing, receiving and inventory management, quality release, and reconciliation.
The ideal candidate is well-versed in industry standards and best practices that are scalable, compliant, and aligned with our future-state operating model. You bring deep supply chain expertise, proven cross-functional leadership, and a strong track record of driving transformation through effective business process and technology alignment.
If you are passionate about building leading-class supply chain capabilities and enabling organizational transformation in a fast-paced, innovative environment, we invite you to apply and make a meaningful impact on the future of healthcare.
#LI-JN1
Equal Opportunity
We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.
Recruitment Fraud Notice
Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent Vaxcyte in recruitment activities. Vaxcyte has an established recruitment process for all positions prior to issuing an offer for employment and we will never extend unsolicited employment offers or ask candidates to provide financial or sensitive personal information as part of the application process. All legitimate communication from Vaxcyte will come from an official @vaxcyte.com email address. Qualified and interested candidates should apply to current openings at vaxcyte.com/careers.
Vaxcyte develops vaccines to prevent bacterial infections, focusing on broad-spectrum pneumococcal vaccines and other targets like Group A Strep, periodontitis, and Shigella. Its lead product, VAX-24, covers 24 Streptococcus pneumoniae strains and is produced using the XpressCF cell-free protein synthesis platform, which enables multi-strain conjugate vaccines. The company differentiates itself by combining cell-free manufacturing with broad strain coverage and has FDA Breakthrough Therapy designation for VAX-24, helping speed development. Its goal is to bring broadly protective bacterial vaccines to market, reduce serious infections worldwide, and expand its portfolio with products like VAX-31 and additional preclinical candidates.
Explore more opportunities at Vaxcyte